Status:
UNKNOWN
The Effect of Infliximab on Sperm Quality
Lead Sponsor:
Tel-Aviv Sourasky Medical Center
Conditions:
Crohn's Disease
Ulcerative Colitis
Eligibility:
MALE
18+ years
Brief Summary
Background: The treatment of inflammatory bowel diseases (IBD) is based mainly on 3 compounds: 1- 5 aminosalysilates . 2- immunomodulators (Azathioprines). 3- Biologic therapies (Infliximab, Adalimuma...
Eligibility Criteria
Inclusion
- Male above the age of 18
- Capable of giving informed consent
- Diagnosed with IBD at least 3 months
- Patients that are going to start a treatment with on of the following groups: 5ASA, Azathioprines, infliximab or ADAlimumab
- Patients that are treated with therapies mentioned in article 4 for at least 3 months
Exclusion
- Male younger than 18
Key Trial Info
Start Date :
October 1 2008
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
Estimated Enrollment :
100 Patients enrolled
Trial Details
Trial ID
NCT00745329
Start Date
October 1 2008
Last Update
September 3 2008
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.